Literature DB >> 3926833

Treatment of bulimia and rapid-cycling bipolar disorder with sodium valproate: a case report.

P L Herridge, H G Pope.   

Abstract

Sodium valproate, a medication sometimes effective in bipolar disorder, produced a rapid remission of previously refractory bulimia and affective symptoms in a young woman. Like other medications used to treat major affective disorder, valproate may benefit certain patients with bulimia.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3926833

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


  6 in total

Review 1.  Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder.

Authors:  S Krüger; S H Kennedy
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 2.  Is anorexia nervosa a neuropsychological disease?

Authors:  C M Braun; M J Chouinard
Journal:  Neuropsychol Rev       Date:  1992-06       Impact factor: 7.444

3.  An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.

Authors:  A Carlo Altamura; Marta Serati; Alessandra Albano; Riccardo A Paoli; Ira D Glick; Bernardo Dell'Osso
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-18       Impact factor: 5.270

Review 4.  Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.

Authors:  Susan L McElroy; Anna I Guerdjikova; Nicole Mori; Francisco Romo-Nava
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

Review 5.  Role of antiepileptic drugs in the management of eating disorders.

Authors:  Susan L McElroy; Anna I Guerdjikova; Brian Martens; Paul E Keck; Harrison G Pope; James I Hudson
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 6.  Rapid cycling bipolar disorder: Literature review on pharmacological treatment illustrated by a case report on ketamine.

Authors:  Alexis Bourla; Florian Ferreri; Thomas Baudry; Vincent Panizzi; Vladimir Adrien; Stéphane Mouchabac
Journal:  Brain Behav       Date:  2022-01-18       Impact factor: 2.708
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.